HIYH Impact Report 2023 | Page 44

Impacts and outcomes of our support
Impacts and outcomes of our support
The latest round of SBRI funding , which saw PinPoint awarded with £ 1m , will see the technology being rolled-out across other areas of England with support from the Health Innovation Network , in particular Kent Surrey Sussex and the health innovation network for North West Coast .
At present PinPoint is in an evaluation stage having received this investment to accelerate progress . As a result of this injection of funding , GPs onboarding in West Yorkshire have tripled and we are supporting this activity to help maintain momentum . Once the evaluation is completed and data is available to demonstrate the effectiveness of the test , this innovation will be strongly placed to spread into other parts of the NHS .
We ’ re working with Pinpoint and the West Yorkshire Cancer Alliance to onboard as many surgeries across West Yorkshire as possible with the objective to offer the PinPoint test to all patients referred on to a ‘ two week wait ’ pathway .
2021-22 data suggests up to 20 % of current two week wait referrals could be safely ruled out and rapidly triaged into the correct patient pathway via the PinPoint green flag system . This equates to 560,000 patients per year . A less pressured two week wait pathway will further improve early detection and clinical outcomes . A 2022 paper on capacity modelling in the Leeds Teaching Hospitals NHS Trust ’ s breast clinic has also shown definitively that the PinPoint Test has the potential to positively impact urgent suspected breast cancer referrals .
44 Transforming Lives Through Innovation